Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet

NCT02400333 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca